127 related articles for article (PubMed ID: 3653181)
1. VP-16 in advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma group.
Dombernowsky P; Buesa J; Pinedo HM; Santoro A; Mouridsen H; Somers R; Bramwell V; Onsrud M; Rouesse J; Thomas D
Eur J Cancer Clin Oncol; 1987 May; 23(5):579-80. PubMed ID: 3653181
[No Abstract] [Full Text] [Related]
2. Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma Group.
Somers R; Santoro A; Verweij J; Lucas P; Rouëssé J; Kok T; Casali A; Seynaeve C; Thomas D
Eur J Cancer; 1992; 28A(4-5):855-7. PubMed ID: 1524907
[No Abstract] [Full Text] [Related]
3. Phase II study of 1,2,4-triglycidyl urasol (TGU) in advanced soft tissue sarcoma. A trial of the EORTC Soft Tissue and Bone Sarcoma Cooperative Group.
Rouëssé JG; van Oosterom AT; Capellaere P; Kerbrat P; van Coninge CJ; Thomas D; Benshahar D
Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1413-4. PubMed ID: 3678328
[No Abstract] [Full Text] [Related]
4. A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma. An EORTC Soft Tissue and Bone Sarcoma Group Study.
Blackledge G; Verweij J; Fuchs R; Keizer HJ; Somers R; Rankin E; Kerbrat P; van Oosterom A; Sylvester R; Thomas D
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1891-3. PubMed ID: 2632271
[No Abstract] [Full Text] [Related]
5. Doxorubicin in relapsed soft tissue sarcoma: justification of phase II evaluation of new drugs in this disease. An EORTC Soft Tissue and Bone Sarcoma Group Study.
Blackledge G; van Oosterom A; Mouridsen H; Steward WP; Buesa J; Thomas D; Sylvester R; Rouesse J
Eur J Cancer; 1990 Feb; 26(2):139-41. PubMed ID: 2138908
[No Abstract] [Full Text] [Related]
6. Phase II trial of methylene dimethane sulphonate (MDMS) in advanced soft tissue sarcomas of the adult. A study of the EORTC Soft Tissue and Bone Sarcoma Group.
Steward WP; Mouridsen HT; Kerbrat P; Somers R; Verweij J; Van Oosterom AT; Blackledge G; Havsteen H; Thomas D; Sylvester R
Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1251-3. PubMed ID: 2767113
[No Abstract] [Full Text] [Related]
7. Phase II study of miltefosine (hexadecylphosphocholine) in advanced soft tissue sarcomas of the adult--an EORTC Soft Tissue and Bone Sarcoma Group Study.
Verweij J; Krzemieniecki K; Kok T; Poveda A; van Pottelsberghe C; van Glabbeke M; Mouridsen H
Eur J Cancer; 1993; 29A(2):208-9. PubMed ID: 8422284
[TBL] [Abstract][Full Text] [Related]
8. Mitomycin C (MCC) in advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group.
van Oosterom AT; Santoro A; Bramwell V; Davy M; Mouridsen HT; Thomas D; Sylvester R
Eur J Cancer Clin Oncol; 1985 Apr; 21(4):459-61. PubMed ID: 3924625
[TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced soft tissue sarcomas with low-dose methotrexate: a phase II trial by the European Organization of Research on Treatment for Cancer (EORTC) Soft Tissue and Bone Sarcoma Group.
Buesa JM; Mouridsen HT; Santoro A; Somers R; Bramwell V; van Oosterom AT; Wagener T; Vendrik C; Thomas D
Cancer Treat Rep; 1984 Apr; 68(4):683-4. PubMed ID: 6713423
[No Abstract] [Full Text] [Related]
10. Treatment of advanced soft tissue sarcoma with chlorozotocin: a phase II trial of the EORTC soft tissue and bone sarcoma group.
Mouridsen HT; Bramwell VH; Lacave J; Metz R; Vendrik C; Hild J; McCreanney J; Sylvester R
Cancer Treat Rep; 1981; 65(5-6):509-11. PubMed ID: 6453646
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of fotemustine in advanced soft tissue sarcomas. A trial of the EORTC Soft Tissue and Bone Sarcoma Group.
Kerbrat P; Somers R; Verweij J; Crowther D; Tursz T; Santoro A; Steward WP; Lentz MA; van Glabbeke M; Mouridsen HT
Eur J Cancer; 1992; 29A(1):143-4. PubMed ID: 1445732
[No Abstract] [Full Text] [Related]
12. Phase II study of liposomal muramyl tripeptide phosphatidylethanolamine (MTP/PE) in advanced soft tissue sarcomas of the adult. An EORTC Soft Tissue and Bone Sarcoma Group study.
Verweij J; Judson I; Steward W; Coleman R; Woll P; van Pottelsberghe C; van Glabbeke M; Mouridsen H
Eur J Cancer; 1994; 30A(6):842-3. PubMed ID: 7917546
[TBL] [Abstract][Full Text] [Related]
13. Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group.
Mouridsen HT; Bastholt L; Somers R; Santoro A; Bramwell V; Mulder JH; van Oosterom AT; Buesa J; Pinedo HM; Thomas D
Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1477-83. PubMed ID: 3479329
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of cisplatin and etoposide in children with advanced soft tissue sarcoma: a report from the Italian Cooperative Rhabdomyosarcoma Group.
Carli M; Perilongo G; di Montezemolo LC; De Bernardi B; Ceci A; Paolucci G; Pianca C; Calculli G; Di Tullio MT; Grotto P
Cancer Treat Rep; 1987 May; 71(5):525-7. PubMed ID: 3567976
[TBL] [Abstract][Full Text] [Related]
15. N-(phosphonacetyl)-L-aspartate (PALA) in advanced soft tissue sarcoma: a phase II trial of the EORTC soft tissue sarcoma group.
Bramwell V; Van Oosterom A; Mouridsen HT; Cheix F; Somers R; Thomas D; Rozencweig M
Eur J Cancer Clin Oncol; 1982 Jan; 18(1):81-4. PubMed ID: 6211362
[TBL] [Abstract][Full Text] [Related]
16. Etoposide for soft tissue sarcomas: fact or fiction.
Verweij J
Eur J Cancer; 1997 Sep; 33(10):1527-8. PubMed ID: 9389909
[No Abstract] [Full Text] [Related]
17. Phase II study of ifosfamide + adriamycin in advanced soft tissue sarcoma in adults. A preliminary analysis.
Dombernowsky P; Mouridsen H; Schütte J; Santoro A; Rouessé J; Somers R; Stewart W; Pinedo HM; von Oosterom A; Blackledge G
Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S17. PubMed ID: 3815714
[No Abstract] [Full Text] [Related]
18. Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma. The EORTC Soft Tissue and Bone Sarcoma Group.
Schütte J; Mouridsen HT; Stewart W; Santoro A; van Oosterom AT; Somers R; Blackledge G; Verweij J; Dombernowsky P; Thomas D
Eur J Cancer; 1990; 26(5):558-61. PubMed ID: 2144740
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of dianhydrogalactitol in advanced soft tissue and bony sarcomas: a Southwest Oncology Group study.
Thigpen JT; Samson MK
Cancer Treat Rep; 1979 Apr; 63(4):553-5. PubMed ID: 445509
[No Abstract] [Full Text] [Related]
20. Phase II. Evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcoma.
Sordillo PP; Magill GB; Gralla RJ; Golbey RB
Cancer Treat Rep; 1980; 64(10-11):1129-30. PubMed ID: 6893950
[No Abstract] [Full Text] [Related]
[Next] [New Search]
